• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特人口中的二级基因组发现率。

The rate of secondary genomic findings in the Saudi population.

机构信息

Division of Translational Pathology, Department of Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

出版信息

Am J Med Genet A. 2022 Jan;188(1):83-88. doi: 10.1002/ajmg.a.62491. Epub 2021 Sep 13.

DOI:10.1002/ajmg.a.62491
PMID:34515413
Abstract

Secondary findings (SF) are defined as genetic conditions discovered unintentionally during an evaluation of raw data for another disease. We aimed to identify the rate of secondary genetic findings in the Saudi population in the 59 genes of the American College of Medical Genetics and Genomics (ACMG) list. In our study, the raw data of 1254 individuals, generated from exome sequencing for clinical purposes, were studied. Variants detected in the 59 genes on the ACMG list of secondary findings were investigated. Pathogenicity classifications were assigned to those variants based on the ACMG scoring system. We identified 2409 variants in the 59 gene list, 45 variants were classified as pathogenic/likely pathogenic variants according to the ACMG classification. The LDLR gene had the greatest number of pathogenic/likely pathogenic variants 12%. Cardiovascular genetic diseases had the highest frequency of disorders detected as secondary findings. In this study, the overall rate of positive cases identified with secondary findings in the Saudi population was 8%. The different in our current study and the previous studies in Saudi Arabia can be explained by the differences between the sequencing method, the criteria used for variant classification, the availability of newer evidence at the time of the publication, and the fact that we identified Saudi novel variants never reported in other populations.

摘要

次要发现 (SF) 是指在对另一种疾病的原始数据进行评估时意外发现的遗传状况。我们旨在确定在沙特人群中,59 个美国医学遗传学与基因组学学会 (ACMG) 列表基因中的次要遗传发现的发生率。在我们的研究中,研究了 1254 名个体的外显子组测序的原始数据,这些个体是出于临床目的而生成的。研究了在 ACMG 次要发现基因列表中检测到的 59 个基因中的变体。根据 ACMG 评分系统对这些变体进行了致病性分类。我们在 59 个基因列表中发现了 2409 个变体,根据 ACMG 分类,有 45 个变体被归类为致病性/可能致病性变体。LDLR 基因具有最多的致病性/可能致病性变体 12%。心血管遗传疾病作为次要发现检测到的疾病的频率最高。在这项研究中,沙特人群中确定具有次要发现的阳性病例的总体发生率为 8%。我们目前的研究与沙特阿拉伯以前的研究之间的差异可以通过测序方法、变体分类标准、发布时新证据的可用性以及我们确定的沙特阿拉伯新变体在其他人群中从未报道过的事实来解释。

相似文献

1
The rate of secondary genomic findings in the Saudi population.沙特人口中的二级基因组发现率。
Am J Med Genet A. 2022 Jan;188(1):83-88. doi: 10.1002/ajmg.a.62491. Epub 2021 Sep 13.
2
The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.与 ACMG SF v2.0 相比,ClinSeq 队列中 ACMG SF v3.0 基因列表使可检出变异的比例提高了 22%。
Genet Med. 2022 Mar;24(3):736-743. doi: 10.1016/j.gim.2021.11.012. Epub 2021 Nov 18.
3
Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.1559 个泰国外显子组中 73 个 ACMG 推荐基因的可操作的次要发现。
J Hum Genet. 2022 Mar;67(3):137-142. doi: 10.1038/s10038-021-00982-2. Epub 2021 Oct 8.
4
Whole-exome sequencing of a Saudi epilepsy cohort reveals association signals in known and potentially novel loci.对沙特癫痫队列进行全外显子组测序揭示了已知和潜在新基因座的关联信号。
Hum Genomics. 2022 Dec 20;16(1):71. doi: 10.1186/s40246-022-00444-6.
5
The burden of pathogenic variants in clinically actionable genes in a founder population.在一个奠基人群体中,临床上可操作基因的致病性变异的负担。
Am J Med Genet A. 2021 Nov;185(11):3476-3484. doi: 10.1002/ajmg.a.62472. Epub 2021 Aug 31.
6
Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.美国医学遗传学与基因组学学院/分子病理学协会标准在预测导致胸主动脉瘤和夹层的遗传变异致病性方面表现良好。
J Transl Med. 2022 Jan 25;20(1):42. doi: 10.1186/s12967-022-03251-8.
7
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
8
Secondary findings in 421 whole exome-sequenced Chinese children.421 例全外显子组测序中国儿童的次要发现。
Hum Genomics. 2018 Sep 14;12(1):42. doi: 10.1186/s40246-018-0174-2.
9
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单:一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
10
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单:一项政策声明
Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20.

引用本文的文献

1
ACMG secondary findings in the Brazilian rare genomes project: insights from 5402 genome sequencing.巴西罕见基因组计划中的美国医学遗传学与基因组学学会次要发现:来自5402例基因组测序的见解
J Hum Genet. 2025 May 19. doi: 10.1038/s10038-025-01349-7.
2
Prevalence estimate of sphingosine phosphate lyase insufficiency syndrome in worldwide and select populations.全球及特定人群中鞘氨醇磷酸裂解酶缺乏综合征的患病率估计
Genet Med Open. 2023 Oct 30;2:100840. doi: 10.1016/j.gimo.2023.100840. eCollection 2024.
3
Prospect of genetic disorders in Saudi Arabia.
沙特阿拉伯的遗传疾病前景。
Front Genet. 2023 Sep 20;14:1243518. doi: 10.3389/fgene.2023.1243518. eCollection 2023.
4
Heterogeneity in biomarkers, mitogenome and genetic disorders of the Arab population with special emphasis on large-scale whole-exome sequencing.阿拉伯人群生物标志物、有丝分裂基因组和遗传疾病的异质性,特别强调大规模全外显子组测序。
Arch Med Sci. 2021 Dec 27;19(3):765-783. doi: 10.5114/aoms/145370. eCollection 2023.
5
Secondary findings in a large Pakistani cohort tested with whole genome sequencing.大巴基斯坦队列全基因组测序检测的次要发现。
Life Sci Alliance. 2023 Jan 12;6(3). doi: 10.26508/lsa.202201673. Print 2023 Mar.
6
Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants.针对383名意大利参与者队列进行基于临床外显子组的基因检测板检测,以发现具有医学可操作性的次要发现。
Front Genet. 2022 Nov 10;13:956723. doi: 10.3389/fgene.2022.956723. eCollection 2022.